Akebia Therapeutics, Inc. (AKBA) CEO John Butler on Q1 2021 Results - Earnings Call Transcript

SA Transcripts
153.96K Followers

Q1: 2021-05-10 Earnings Summary

EPS of -$0.45 misses by $0.08
 | Revenue of $52.30M (-40.88% Y/Y) beats by $10.60M

Akebia Therapeutics, Inc. (NASDAQ:AKBA) Q1 2021 Earnings Conference Call May 10, 2021 9:00 AM ET

Company Participants

Kristen Sheppard - Senior Vice President, Investor Relations
John Butler - Chief Executive Officer
David Spellman - Chief Financial Officer

Conference Call Participants

Ally Bratzel - Piper Sandler
Alethia Young - Cantor Fitzgerald
Difei Yang - Mizuho Securities
Bert Hazlett - BTIG
David Lebovitz - Morgan Stanley
Ed Arce - H.C. Wainwright

Operator

Good day, ladies and gentlemen and welcome to Akebia Therapeutics’ First Quarter of 2021 Financial Results and Business Update Conference Call. As a reminder, this call is being recorded. I would now like to introduce your host for today’s event, Kristen Sheppard, Senior Vice President of Investor Relations with Akebia.

Kristen Sheppard

Thank you and welcome to Akebia’s first quarter 2021 financial results and business update conference call. Please note that the press release detailing our results for the first quarter was issued earlier this morning and is available on the Investors section of our website. For your convenience, a replay of today’s call will also be available on our website shortly after we conclude today’s call.

Joining me for today’s event is John Butler, our Chief Executive Officer and David Spellman, our Chief Financial Officer.

Before we begin, I would like to remind everyone that this call includes forward-looking statements. Each forward-looking statement contained in this call is subject to risks and uncertainties that could cause actual results to differ materially from those described in these statements. Additional information regarding these factors is described in the forward-looking statements section of the press release we issued earlier today as well as in the Risk Factors and Management’s Discussion and Analysis sections of our most recent annual and quarterly reports filed with the SEC. The forward-looking statements on this call speak only as of the

Recommended For You

About AKBA Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on AKBA